Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session TrendingStockAlerts · Jun 2, 2025
Biomarkers Market worth US$104.15 billion in 2030 with 10.8% CAGR | MarketsandMarkets™ TrendingStockAlerts · Jun 1, 2025
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA") TrendingStockAlerts · May 31, 2025
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update TrendingStockAlerts · May 30, 2025
Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease TrendingStockAlerts · May 28, 2025
Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC TrendingStockAlerts · May 27, 2025
Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting TrendingStockAlerts · May 26, 2025
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs TrendingStockAlerts · May 25, 2025
Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting TrendingStockAlerts · May 24, 2025
Zentiva and Euractiv Bring Policymakers Together for Health Policy Conference TrendingStockAlerts · May 23, 2025
